Advertisement
Advertisement
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
2.96
USDSponsored
+0.09
+3.00%
Apr 02, 15:59 UTC -4
Closed
After-Market
2.94
-0.01
-0.37%
MRVI Earnings Reports
Positive Surprise Ratio
MRVI beat 13 of 21 last estimates.
62%
Next Report
Date of Next Report
May 11, 2026
Estimate for Q1 26 (Revenue/ EPS)
$54.00M
/-$0.04
Implied change from Q4 25 (Revenue/ EPS)
+8.29%
/--
Implied change from Q1 25 (Revenue/ EPS)
+15.26%
/-50.00%
Maravai LifeSciences Holdings, Inc. Class A Common Stock earnings per share and revenue
On Feb 25, 2026, MRVI reported earnings of -0.04 USD per share (EPS) for Q4 25, beating the estimate of -0.07 USD, resulting in a 44.67% surprise. Revenue reached 49.87 million, compared to an expected 50.03 million, with a -0.32% difference. The market reacted with a +9.20% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of -0.04 USD, with revenue projected to reach 54.00 million USD, implying an increase of 0.00% EPS, and increase of 8.29% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lumexa Imaging Holdings, Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.07
Actual
-$0.66
Surprise
-1005.35%
Omeros Corporation
Report Date
Mar 31, 2026 For Q4 25
Estimate
-$0.58
Actual
$3.14
Surprise
+640.08%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
$0.02
Actual
-$0.01
Surprise
-149.02%
IM Cannabis Corp. Common Shares
Report Date
Mar 30, 2026 For Q4 25
Estimate
$0.12
Actual
-$1.19
Surprise
-1055.53%
FAQ
What were Maravai LifeSciences Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Maravai LifeSciences Holdings, Inc. Class A Common Stock reported EPS of -$0.04, beating estimates by 44.67%, and revenue of $49.87M, -0.32% below expectations.
How did the market react to Maravai LifeSciences Holdings, Inc. Class A Common Stock's Q4 2025 earnings?
The stock price moved up 9.2%, changed from $3.26 before the earnings release to $3.56 the day after.
When is Maravai LifeSciences Holdings, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for May 11, 2026.
What are the forecasts for Maravai LifeSciences Holdings, Inc. Class A Common Stock's next earnings report?
Based on 11
analysts, Maravai LifeSciences Holdings, Inc. Class A Common Stock is expected to report EPS of -$0.04 and revenue of $54.00M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement